Lidocaine for Acromioclavicular Sprain
This trial will compare three different injections to treat ACJ Dysfunction. One group will get a corticosteroid, one group will get Platelet Rich Plasma, and one group will get Lidocaine. Doctors will follow patients for one year to see how well the treatments work.
- Acromioclavicular Sprain (Strain)
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Is there an upper age limit to taking part in this experiment?
"This clinical trial is restricted to those aged between 18 and 65. However, there are 23 trials available for minors and 163 studies targeting patients above the age of retirement."
Are any new participants permitted to sign up for this experiment?
"Affirmative. The clinicaltrials.gov website indicates that this investigation, initially posted on July 1st 2022 and recently adjusted on September 28th 2022, is currently recruiting patients. 150 individuals must be enrolled from 2 separate sites for the trial to commence."
Are there any other explorations of Corticosteroid that have taken place?
"Corticosteroid was first researched at Hamid Ahmadieh, MD in 2005 and has since been the subject of 976 studies. At this time 162 clinical trials are underway, a majority taking place in San Antonio, Texas."
What is the size of the current cohort participating in this research?
"Affirmative. Clinicaltrials.gov shows that this research project, which debuted on July 1st 2022 is currently enrolling participants. Approximately 150 subjects are needed from 2 separate medical facilities."
What potential health risks do Corticosteroids pose to individuals?
"Corticosteroid has been approved, so it earned a score of 3 on our safety scale."
Am I eligible to join the research project?
"The trial is open to a total of 150 individuals aged 18-65 years old suffering from acromioclavicular; sprain (strain). To be eligible, patients should meet the following requirement: Age 18-65 years."